Skip to main content

Animations

MJFF Publications

4531 - 4540 of 6258 Results
Title
Year
  • Year
  • 2013
  • 2019
  • 2019
  • 2017
  • 2018
  • 2016
  • 2022
  • 2024
  • 2011
  • 2023
  • Summary Details
    OPEN
    Title: Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0080705
    Citation Count: 180
  • Summary Details
    OPEN
    Title: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/59758-v
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20170803
    Citation Count: 158
  • Summary Details
    OPEN
    Title: Impact of motor fluctuations on real-life gait in Parkinson’s patients
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.03.045
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Perspective: Data sharing for discovery
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/538s4a
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00404-w
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00789-w
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Association of women-specific health factors in the severity of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00524-x
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.